WO2019035143A2 - Medicated honey and method of preparation thereof - Google Patents
Medicated honey and method of preparation thereof Download PDFInfo
- Publication number
- WO2019035143A2 WO2019035143A2 PCT/IN2018/050531 IN2018050531W WO2019035143A2 WO 2019035143 A2 WO2019035143 A2 WO 2019035143A2 IN 2018050531 W IN2018050531 W IN 2018050531W WO 2019035143 A2 WO2019035143 A2 WO 2019035143A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- honey
- medicated
- medicated honey
- jasminum
- honeybees
- Prior art date
Links
- 235000012907 honey Nutrition 0.000 title claims abstract description 118
- 238000000034 method Methods 0.000 title claims abstract description 45
- 238000002360 preparation method Methods 0.000 title claims description 10
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 25
- 241000256837 Apidae Species 0.000 claims abstract description 19
- 210000000987 immune system Anatomy 0.000 claims abstract description 4
- 238000005728 strengthening Methods 0.000 claims abstract description 4
- 239000002246 antineoplastic agent Substances 0.000 claims abstract description 3
- 239000003814 drug Substances 0.000 claims description 18
- 241000196324 Embryophyta Species 0.000 claims description 14
- 241001247986 Calotropis procera Species 0.000 claims description 12
- 238000012545 processing Methods 0.000 claims description 11
- 206010028980 Neoplasm Diseases 0.000 claims description 10
- 201000011510 cancer Diseases 0.000 claims description 10
- 230000002265 prevention Effects 0.000 claims description 7
- 244000007668 Cassia auriculata Species 0.000 claims description 6
- 235000007436 Cassia auriculata Nutrition 0.000 claims description 6
- 240000001829 Catharanthus roseus Species 0.000 claims description 6
- 240000009027 Couroupita guianensis Species 0.000 claims description 6
- 241000218033 Hibiscus Species 0.000 claims description 6
- 235000005206 Hibiscus Nutrition 0.000 claims description 6
- 235000007185 Hibiscus lunariifolius Nutrition 0.000 claims description 6
- 244000197259 Hibiscus vitifolius Species 0.000 claims description 6
- 235000007187 Hibiscus vitifolius Nutrition 0.000 claims description 6
- 241000156540 Jasminum auriculatum Species 0.000 claims description 6
- 240000005067 Jasminum grandiflorum Species 0.000 claims description 6
- 235000004412 Jasminum grandiflorum Nutrition 0.000 claims description 6
- 240000006989 Jasminum humile Species 0.000 claims description 6
- 235000010258 Jasminum humile Nutrition 0.000 claims description 6
- 235000010254 Jasminum officinale Nutrition 0.000 claims description 6
- 240000008790 Musa x paradisiaca Species 0.000 claims description 6
- 235000018290 Musa x paradisiaca Nutrition 0.000 claims description 6
- 244000085204 Nerium odorum Species 0.000 claims description 6
- 241000131784 Nyctanthes Species 0.000 claims description 6
- 241001480177 Nymphaea alba Species 0.000 claims description 6
- 240000007926 Ocimum gratissimum Species 0.000 claims description 6
- 235000004066 Ocimum gratissimum Nutrition 0.000 claims description 6
- 235000004072 Ocimum sanctum Nutrition 0.000 claims description 6
- 240000002837 Ocimum tenuiflorum Species 0.000 claims description 6
- 244000215777 Plumeria rubra Species 0.000 claims description 6
- 235000013087 Plumeria rubra Nutrition 0.000 claims description 6
- 241000219782 Sesbania Species 0.000 claims description 6
- 235000015392 Sesbania grandiflora Nutrition 0.000 claims description 6
- 240000003411 Tabernaemontana divaricata Species 0.000 claims description 6
- 240000001923 Thevetia neriifolia Species 0.000 claims description 6
- 240000008121 Tridax procumbens Species 0.000 claims description 6
- 244000009874 asok Species 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 6
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 3
- 241000257303 Hymenoptera Species 0.000 claims description 3
- 240000003936 Plumbago auriculata Species 0.000 claims description 3
- 240000002904 Plumbago indica Species 0.000 claims description 3
- 239000010439 graphite Substances 0.000 claims description 3
- 238000004806 packaging method and process Methods 0.000 claims description 3
- 241000220317 Rosa Species 0.000 claims description 2
- 229940079593 drug Drugs 0.000 claims description 2
- 230000001093 anti-cancer Effects 0.000 abstract description 10
- 239000003963 antioxidant agent Substances 0.000 abstract description 9
- 235000006708 antioxidants Nutrition 0.000 abstract description 9
- 238000012360 testing method Methods 0.000 description 36
- 239000000126 substance Substances 0.000 description 23
- 230000003013 cytotoxicity Effects 0.000 description 9
- 231100000135 cytotoxicity Toxicity 0.000 description 9
- 238000000605 extraction Methods 0.000 description 7
- 238000012986 modification Methods 0.000 description 7
- 230000004048 modification Effects 0.000 description 7
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 6
- TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl Chemical compound [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 description 6
- 235000000346 sugar Nutrition 0.000 description 5
- 150000008163 sugars Chemical class 0.000 description 5
- 229940124597 therapeutic agent Drugs 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- 239000000284 extract Substances 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 230000007721 medicinal effect Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000000202 analgesic effect Effects 0.000 description 3
- 230000003255 anti-acne Effects 0.000 description 3
- 230000003266 anti-allergic effect Effects 0.000 description 3
- 230000003178 anti-diabetic effect Effects 0.000 description 3
- 230000000845 anti-microbial effect Effects 0.000 description 3
- 230000000767 anti-ulcer Effects 0.000 description 3
- 230000000840 anti-viral effect Effects 0.000 description 3
- 239000003472 antidiabetic agent Substances 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 230000001767 chemoprotection Effects 0.000 description 3
- 230000001120 cytoprotective effect Effects 0.000 description 3
- 230000001472 cytotoxic effect Effects 0.000 description 3
- 230000000641 filaricidal effect Effects 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000002443 hepatoprotective effect Effects 0.000 description 3
- 235000008216 herbs Nutrition 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 238000010079 rubber tapping Methods 0.000 description 3
- 230000029663 wound healing Effects 0.000 description 3
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- -1 analgesic Substances 0.000 description 2
- 239000002221 antipyretic Substances 0.000 description 2
- 229940125716 antipyretic agent Drugs 0.000 description 2
- OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000012676 herbal extract Substances 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000000050 nutritive effect Effects 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 1
- 241000256846 Apis cerana Species 0.000 description 1
- 241000358061 Apis cerana indica Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- VTLYFUHAOXGGBS-UHFFFAOYSA-N Fe3+ Chemical compound [Fe+3] VTLYFUHAOXGGBS-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 240000003553 Leptospermum scoparium Species 0.000 description 1
- 235000016887 Leptospermum scoparium Nutrition 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 241000219071 Malvaceae Species 0.000 description 1
- 244000237986 Melia azadirachta Species 0.000 description 1
- 235000013500 Melia azadirachta Nutrition 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- MMCPOSDMTGQNKG-UHFFFAOYSA-N anilinium chloride Chemical compound Cl.NC1=CC=CC=C1 MMCPOSDMTGQNKG-UHFFFAOYSA-N 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 229940038481 bee pollen Drugs 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 244000144987 brood Species 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 201000006662 cervical adenocarcinoma Diseases 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 229910001447 ferric ion Inorganic materials 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 201000005296 lung carcinoma Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 238000009928 pasteurization Methods 0.000 description 1
- 230000005195 poor health Effects 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/90—Feeding-stuffs specially adapted for particular animals for insects, e.g. bees or silkworms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L21/00—Marmalades, jams, jellies or the like; Products from apiculture; Preparation or treatment thereof
- A23L21/20—Products from apiculture, e.g. royal jelly or pollen; Substitutes therefor
- A23L21/25—Honey; Honey substitutes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K51/00—Appliances for treating beehives or parts thereof, e.g. for cleaning or disinfecting
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K59/00—Honey collection
Definitions
- the embodiments disclosed in this specification relates to medicated honey, and more particularly to its anti-cancer and anti-oxidant properties. It also relates to the process for the preparation of medicated honey. BACKGROUND
- Honey a syrupy sweet liquid naturally produced by Honeybees has always had a special place since ancient times. Honeybees collect nectar from various flowers which is then converted to honey by enzymatic activity and regurgitation.
- Raw honey is usually murky and comprises of increased levels of bee pollen, amino acids, sugars, antimicrobial agents and anti-oxidants.
- Honey that is commercially available is processed and is clear in appearance. Processing of honey is usually performed by heating and straining under specific conditions before packaging to ensure it is devoid of local contamination and debris. However, many nutrients that are heat sensitive disintegrate during this process and hence may be lost during processing making the product less nutritive.
- Honey in any form is known to possess therapeutic properties. Since ancient times, honey has been used to treat wounds, ulcers, skin conditions, etc. It is also used to improve digestion, relieve nausea, lower cholesterol, reduce inflammation, relieve sore throat and enhance taste among other uses. In Ayurveda, honey is considered as a medicine and a medium for administering medicine. It is used in formulations containing herbs, minerals, etc. to treat stomach, skin, eyes, heart, lungs, mouth, and so on.
- honey varies in flavor and appearance depending on the source of the nectar. Some of the commonly known types include Buckwheat honey, Neem honey, Basswood honey, Acacia honey, Manuka honey and so on.
- the flower source used by honeybees to produce honey is known to influence the quality of honey. The therapeutic attributes of the source are often reflected in the attributes of the honey obtained.
- the principal object of the embodiments disclosed herein is to provide a method of producing medicated honey.
- Another object of the invention is to provide honey having medicinal properties, such as anti-oxidant and anti-cancer properties.
- Yet another object of the invention is to provide a method for the management/prevention of cancer.
- FIG. 1 depicts a flowchart for method of honey extraction
- Fig. 2 depicts a flowchart for method of honey tapping
- FIG. 3 depicts a flowchart for method of obtaining processed honey from raw honey; according to embodiments as disclosed herein.
- honey having medicinal properties, and a process for its preparation.
- the honey disclosed in the various embodiments herein is medicated honey having anti-oxidant and anti-cancer properties.
- Medicinal properties may further include antimicrobial, antiulcer, cytoprotective, chemoprotective, wound healing, anti- acne, hepatoprotective, antiviral, filaricidal, anti-allergy, anti-diabetic, analgesic, antipyretic properties and so on.
- the embodiments herein also achieve a medicated honey instrumental as an anti-oxidating and anti-cancer agent.
- the medicated honey may also be used to prepare medicament having anti-oxidative and anti-cancer properties.
- Further embodiments disclose a method for the management or prevention of cancer. Also disclosed herein are methods of improving general health.
- the disclosed embodiments further include a method of producing medicated honey.
- the method includes feeding honeybees with bee-feed obtained from various medicinal plants.
- the medicinal plants may be any plant including herbs, shrubs, trees, vines, etc that is known to have medicinal properties.
- the medicated honey is one having anti-oxidant properties. In another embodiment, the medicated honey is such that it includes anti-cancer properties. [0021] In an embodiment, the medicated honey is one that is obtained by feeding honeybees with bee-feed obtained from at least one of Plumeria rubra, Vinca rosea, Ageretum conzyoides, Calotropis gigantea, Calotropis procera, Nerium indicum, Thevetia neriifolia, Jasminum officinale, Jasminum auriculatum, Musa paradisiaca, Jasminum humile, Nyctanthes abor-tristis, Ocimum sanctum, Ocimum gratissimum, Tabernaemontana divaricata, Tridax procumbens, Cassia auriculata, Hibiscus vitifolius, Sesbania grandiflora,
- the honey obtained may be combined with other ingredients such as minerals, vitamins, amino acids, herbal extracts, therapeutic agents, etc.
- the therapeutic agents that may be used include anti-oxidants, anticancer, antimicrobial, antiulcer, cytoprotective, chemoprotective, wound healing, anti-acne, hepatoprotective, antiviral, filaricidal, anti-allergy, anti-diabetic, analgesic, antipyretic agents and so on.
- the medicated honey obtained may further be used to prepare medicament of therapeutic value.
- Table. 1 is a table illustrating the characteristics of an embodiment of medicated honey disclosed herein.
- Solubility bottom, on mixing well bottom, on mixing well dissolves dissolves in water and alcohol. in water and alcohol.
- the honey is such that it is translucent, yellowish dark brown, viscous liquid, having 72.5% invert sugars and 0.12% sucrose.
- the honey tested positive for reducing sugars, Selivanoff s test and Fiehe's test, and negative for Aniline chloride test and Test for dextrin.
- honeybees employed to obtain the medicated honey disclosed in the various embodiments herein may be of any species known in the art.
- the honeybees used may be of the species Apis indica or Apis cerena.
- the method includes providing honeybees with bee-feed obtained from medicinal plants having anti-cancer and anti-oxidant properties; extracting the honey produced by the honeybees; and processing the extracted honey.
- the bee-feed used may include plant nectar and/or herb extract/decoction of medicinal plants.
- the bee-feed is plant nectar of atleast one of Plumeria rubra, Vinca rosea, Ageretum conzyoides, Calotropis gigantea, Calotropis procera, Nerium indicum, Thevetia neriifolia, Jasminum officinale, Jasminum auriculatum, Musa paradisiaca, Jasminum humile, Nyctanthes abor-tristis, Ocimum sanctum, Ocimum gratissimum, Tabernaemontana divaricata, Tridax procumbens, Cassia auriculata, Hibiscus vitifolius, Sesbania grandiflora, Nymphaea alba, Saraca asoca, Hibiscus alba, Couroupita guianensis and Plumbago reosea.
- the bee-feed may alternatively or additionally include a herb extract obtained from atleast one of Plumeria rubra, Vinca rosea, Ageretum conzyoides, Calotropis gigantea, Calotropis procera, Nerium indicum, Thevetia neriifolia, Jasminum officinale, Jasminum auriculatum, Musa paradisiaca, Jasminum humile, Nyctanthes abor-tristis, Ocimum sanctum, Ocimum gratissimum, Tabernaemontana divaricata, Tridax procumbens, Cassia auriculata, Hibiscus vitifolius, Sesbania grandiflora, Nymphaea alba, Saraca asoca, Hibiscus alba, Couroupita guianensis and Plumbago reosea.
- a herb extract obtained from atleast one of Plumeria rubra, Vinca rosea, Agere
- the herb extract may be obtained by techniques generally known in the art such as grinding, extraction, boiling, centrifugation, etc, of one or more medicinal plants.
- the method includes maintaining a controlled system.
- the controlled system may be conditions that are generally considered suitable for honeybees to produce honey.
- the controlled system includes maintaining a condition wherein the temperature is in the range of 32°C and 36°C and relative humidity is in the range of 60% to75%.
- the beefeed may be provided for a preferable period of about 100 to 150 days. It would be apparent to a person skilled in the art that many modifications in the method may be practiced without departing from the scope of the present invention.
- the honey produced by the bees upon providing the bee-feed may be extracted by method generally known in the field.
- extraction may be performed by removing honey super, looking for brood and managing appropriately, moving honey into hot houses and extracting honey using an extractor.
- the honey supers, after extraction may further be stored or returned to the hive.
- extraction of honey may be performed by generally known commercial extractors.
- Fig. 1 depicts a flowchart for method of honey extraction.
- extraction of honey may be performed by honey tapping using flow frame bee hives.
- Fig. 2 illustrates the method of flow frame technique of honey tapping.
- the flow frame beehives have partly formed honeycomb cells that are completed by the honeybees to store honey. Once the honeybees complete the comb cells with their wax and fill the cells with honey and cap it, honey can be extracted by opening the tap. Opening the tap will split the comb cells vertically allowing the honey to flow down which may then be collected without disturbing the honeybees.
- the honey produced according to the various embodiments herein may further be processed by method generally known in the field.
- processing may be performed by techniques such as heating directly or indirectly, straining, filtration, etc.
- the raw honey is filtered and then heated under controlled conditions.
- Controlled conditions may be conditions suitable to purify and prevent honey from granulation.
- controlled conditions for processing include controlled temperature of about 61°C to 63°C, for a maximum period of about 30 minutes and until the humidity is within the range of 18% to 22%.
- heating is performed to ensure pasteurization and may be performed by using a power blanket or direct heat.
- the method of preparation of medicated honey may further include packaging of the processed honey in airtight amber color containers. It would be apparent to a person skilled in the art that many modifications in the method may be practiced without departing from the scope of the present invention.
- Fig. 3 depicts a flowchart for method of processing medicated honey as disclosed in the various embodiments herein.
- the method includes administering to a subject a suitable amount of medicated honey disclosed in the various embodiments herein.
- Embodiments of the Disclosed composition may also find use in the preparation of a medicament having antioxidant properties. It may also be used in the preparation of medication for the prevention/management of cancer. Further embodiments of the disclosed composition may also be used as a medium for the administration of medicine.
- the term medicine may include any ayurvedic or allopathic medicine which may be mixed or triturated to improve its absorption or palatability. It may further include any therapeutic agent known to be administered with honey.
- the honey administered may be raw honey or processed honey.
- the honey may be combined with other ingredients such as minerals, vitamins, amino acids, herbal extracts, therapeutic agents, etc.
- the therapeutic agents include anti-oxidants, anticancer, antimicrobial, antiulcer, cytoprotective, chemoprotective, wound healing, anti-acne, hepatoprotective, antiviral, filaricidal, anti-allergy, anti-diabetic, analgesic, antipyretic agents and so on.
- Subject may include any individual, child or adult.
- subject includes an individual having cancer.
- subject includes any individual having poor health conditions.
- the disclosed honey may be used to improve general health of any individual. Accordingly, the subject may include any individual looking at improving general health.
- Embodiments of the Disclosed formulation (also referred as Test substance) was further evaluated for cytotoxicity and anti-oxidant properties by studies, as described hereunder by way of examples. Embodiments are further described by reference to the following examples by way of illustration only and should not be construed to limit the scope of the claims provided herewith. It will be apparent to those skilled in the art that many modifications, both to materials and methods, may be practiced without departing from the scope of the claims.
- Example 1 Evaluation of in vitro cytotoxicity of medicated honey on selected cell lines
- test substance In-vitro cytotoxicity of the test substance (medicated honey) was tested by MTT on A549 (Human Lung Carcinoma), HeLa (Human Cervix Adenocarcinoma) and HL-60 (Human promyeloblast leukemia) cell lines.
- the test substance was taken at concentrations ranging from 1000 ⁇ g/ml to 7.& ⁇ / ⁇ (i.e. 1000 ⁇ g/ml, 500 ⁇ g/ml, 250 ⁇ g/ml, 125 ⁇ g/ml, 62 ⁇ g/ml, 31.25 ⁇ / ⁇ 1, 15 ⁇ g/ml and 7 ⁇ g/ml) to determine the percentage growth inhibition on the cell lines A549 and HeLa.
- Test substance exhibited a CTC50 value of >1000 on all three cell lines (A549, HeLa and HL-60).
- Table 2 depicts the Cytotoxicity levels of test substance against A549 cell line.
- Table 3 depicts the Cytotoxicity levels of test substance against HeLa cell line.
- Table 4 depicts the Cytotoxicity levels of test substance against HL-60 cell line.
- Example 2 Evaluation of antioxidant activity of medicated honey. [0045] Objective: To assess the antioxidant activity of medicated honey by ABTS,
- Nitric oxide, Hydroxyl radical and Reducing power assay method Nitric oxide, Hydroxyl radical and Reducing power assay method.
- the antioxidant activity of the test samples exhibited the IC50 value of greater than 1000.
- the reducing power assay revealed the RPA value ranging from 0.082 to 0.024 for Medicated honey.
- Table 5 depicts the antioxidant activity of test substance for ABTS radical.
- Table 6 depicts the antioxidant activity of test substance for Nitric oxide radical.
- Table 7 depicts the antioxidant activity of test substance for Hydroxyl radical.
- Table 8 depicts the antioxidant activity of test substance for Hydroxyl radical.
- Table 8 The antioxidant activity of test substance for Hydroxyl radical
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Insects & Arthropods (AREA)
- Birds (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Physiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Botany (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nutrition Science (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Feed For Specific Animals (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Medicated honey and method of preparing the same are disclosed herein. The disclosed honey is obtained by feeding honeybees with bee-feed obtained from medicinal plants. The medicated honey disclosed herein is such that it has anti-oxidant and anti-cancer properties. The embodiments disclosed herein may be instrumental in strengthening the immune system, as an anti-cancer agent and as an anti-oxidant.
Description
"Medicated honey and method of preparation thereof
CROSS REFERENCE TO RELATED APPLICATION
This application is based on and derives the benefit of Indian Provisional Application IN 201741029072 filed on 16th August 2017, the contents of which are incorporated herein by reference in their entirety.
TECHNICAL FIELD
[001] The embodiments disclosed in this specification relates to medicated honey, and more particularly to its anti-cancer and anti-oxidant properties. It also relates to the process for the preparation of medicated honey. BACKGROUND
[002] Honey, a syrupy sweet liquid naturally produced by Honeybees has always had a special place since ancient times. Honeybees collect nectar from various flowers which is then converted to honey by enzymatic activity and regurgitation.
[003] Raw honey is usually murky and comprises of increased levels of bee pollen, amino acids, sugars, antimicrobial agents and anti-oxidants. Honey that is commercially available is processed and is clear in appearance. Processing of honey is usually performed by heating and straining under specific conditions before packaging to ensure it is devoid of local contamination and debris. However, many nutrients that are heat sensitive disintegrate during this process and hence may be lost during processing making the product less nutritive. [004] Honey in any form is known to possess therapeutic properties. Since ancient times, honey has been used to treat wounds, ulcers, skin conditions, etc. It is also used to improve digestion, relieve nausea, lower cholesterol, reduce inflammation, relieve sore throat and enhance taste among other uses. In Ayurveda, honey is considered as a medicine and a medium for administering medicine. It is used in formulations containing herbs, minerals, etc. to treat stomach, skin, eyes, heart, lungs, mouth, and so on.
[005] Numerous varieties of honey are known. Honey varies in flavor and appearance depending on the source of the nectar. Some of the commonly known types include Buckwheat honey, Neem honey, Basswood honey, Acacia honey, Manuka honey and so on. The flower
source used by honeybees to produce honey is known to influence the quality of honey. The therapeutic attributes of the source are often reflected in the attributes of the honey obtained.
[006] Various attempts have been made to obtain honey having specific therapeutic properties by creating an ecosystem for the cultured bees to feed on selected flowers. Given the increasing burden of diseases including cancer and other lifestyle diseases on the society, there is a growing need for identifying and obtaining rich sources of antioxidants. Several fruits, medicinal plants and herbs are known for its antioxidative and anti-cancerous properties. There is however a need for preparation of honey which is not only nutritive but also rich in antioxidant. OBJECTS OF THE DISCLOSED EMBODIMENTS
[007] The principal object of the embodiments disclosed herein is to provide a method of producing medicated honey.
[008] Another object of the invention is to provide honey having medicinal properties, such as anti-oxidant and anti-cancer properties. [009] Yet another object of the invention is to provide a method for the management/prevention of cancer.
[0010] These and other objects of the embodiments herein will be better appreciated and understood when considered in conjunction with the following description and the accompanying drawings. It should be understood, however, that the following descriptions, while indicating preferred embodiments and numerous specific details thereof, are given by way of illustration and not of limitation. Many changes and modifications may be made within the scope of the embodiments herein without departing from the spirit thereof, and the embodiments herein include all such modifications.
BRIEF DESCRIPTION OF FIGURES [0011] The embodiments disclosed herein are illustrated in the accompanying drawings, throughout which like reference letters indicate corresponding parts in the various figures. The embodiments herein will be better understood from the following description with reference to the drawings, in which:
[0012] Fig. 1 depicts a flowchart for method of honey extraction;
[0013] Fig. 2 depicts a flowchart for method of honey tapping; and
[0014] Fig. 3 depicts a flowchart for method of obtaining processed honey from raw honey; according to embodiments as disclosed herein.
DETAILED DESCRIPTION
[0015] The embodiments herein and the various features and advantageous details thereof are explained more fully with reference to the non-limiting embodiments that are illustrated in the accompanying drawings and detailed in the following description. Descriptions of well-known components and processing techniques are omitted so as to not unnecessarily obscure the embodiments herein. The examples used herein are intended merely to facilitate an understanding of ways in which the embodiments disclosed here may be practiced and to further enable those of skill in the art to practice these embodiments. Accordingly, the examples should not be construed as limiting the scope of the embodiments herein.
[0016] The embodiments herein achieve honey having medicinal properties, and a process for its preparation. The honey disclosed in the various embodiments herein is medicated honey having anti-oxidant and anti-cancer properties. Medicinal properties may further include antimicrobial, antiulcer, cytoprotective, chemoprotective, wound healing, anti- acne, hepatoprotective, antiviral, filaricidal, anti-allergy, anti-diabetic, analgesic, antipyretic properties and so on.
[0017] The embodiments herein also achieve a medicated honey instrumental as an anti-oxidating and anti-cancer agent. In various embodiments, the medicated honey may also be used to prepare medicament having anti-oxidative and anti-cancer properties. [0018] Further embodiments disclose a method for the management or prevention of cancer. Also disclosed herein are methods of improving general health.
[0019] The disclosed embodiments further include a method of producing medicated honey. In an embodiment, the method includes feeding honeybees with bee-feed obtained from various medicinal plants. The medicinal plants may be any plant including herbs, shrubs, trees, vines, etc that is known to have medicinal properties.
Medicated honey
[0020] Disclosed herein are embodiments of medicated honey of therapeutic value. In an embodiment, the medicated honey is one having anti-oxidant properties. In another embodiment, the medicated honey is such that it includes anti-cancer properties. [0021] In an embodiment, the medicated honey is one that is obtained by feeding honeybees with bee-feed obtained from at least one of Plumeria rubra, Vinca rosea, Ageretum
conzyoides, Calotropis gigantea, Calotropis procera, Nerium indicum, Thevetia neriifolia, Jasminum officinale, Jasminum auriculatum, Musa paradisiaca, Jasminum humile, Nyctanthes abor-tristis, Ocimum sanctum, Ocimum gratissimum, Tabernaemontana divaricata, Tridax procumbens, Cassia auriculata, Hibiscus vitifolius, Sesbania grandiflora, Nymphaea alba, Saraca asoca, Hibiscus alba, Couroupita guianensis and Plumbago rosea. In an embodiment, the bee-feed may include nectar of the medicinal plants. In another embodiment, the bee-feed may include an extract obtained from the medicinal plants.
[0022] In an embodiment, the honey obtained may be combined with other ingredients such as minerals, vitamins, amino acids, herbal extracts, therapeutic agents, etc. The therapeutic agents that may be used include anti-oxidants, anticancer, antimicrobial, antiulcer, cytoprotective, chemoprotective, wound healing, anti-acne, hepatoprotective, antiviral, filaricidal, anti-allergy, anti-diabetic, analgesic, antipyretic agents and so on. In an embodiment, the medicated honey obtained may further be used to prepare medicament of therapeutic value.
[0023] Table. 1 is a table illustrating the characteristics of an embodiment of medicated honey disclosed herein.
[0024] Table 1;
Physical constants API standards Values in the sample
Nature Viscous, translucent liquid. Viscous, translucent liquid.
Color Yellowish to dark brown Yellowish to dark brown
Odor Agreeable Agreeable
Taste Sweet Sweet
Initially settles as a lump at the Initially settles as a lump at the
Solubility bottom, on mixing well bottom, on mixing well dissolves dissolves in water and alcohol. in water and alcohol.
Invert Sugars 70-80% 72.50%
Sucrose 0.1-10% 0.12%
Flame test Burns Burns
Totally absorbed into blotting Totally absorbed into blotting
Absorption test
paper paper
Test for reducing
Positive Positive
sugars
Selivanoff s test Rose color indicating glucose Positive
Test for dextrin Negative Negative
Fiehe's test Transient red color Positive
Anilin chloride test Absence of red/crimson color No crimson/red colour appleared
[0025] In an embodiment, the honey is such that it is translucent, yellowish dark brown, viscous liquid, having 72.5% invert sugars and 0.12% sucrose. In an embodiment, the honey tested positive for reducing sugars, Selivanoff s test and Fiehe's test, and negative for Aniline chloride test and Test for dextrin.
[0026] The honeybees employed to obtain the medicated honey disclosed in the various embodiments herein may be of any species known in the art. In an embodiment, the honeybees used may be of the species Apis indica or Apis cerena.
Method
[0027] Disclosed herein are embodiments of a method for producing medicated honey.
In an embodiment, the method includes providing honeybees with bee-feed obtained from medicinal plants having anti-cancer and anti-oxidant properties; extracting the honey produced by the honeybees; and processing the extracted honey.
[0028] . The bee-feed used may include plant nectar and/or herb extract/decoction of medicinal plants. In an embodiment, the bee-feed is plant nectar of atleast one of Plumeria rubra, Vinca rosea, Ageretum conzyoides, Calotropis gigantea, Calotropis procera, Nerium indicum, Thevetia neriifolia, Jasminum officinale, Jasminum auriculatum, Musa paradisiaca, Jasminum humile, Nyctanthes abor-tristis, Ocimum sanctum, Ocimum gratissimum, Tabernaemontana divaricata, Tridax procumbens, Cassia auriculata, Hibiscus vitifolius, Sesbania grandiflora, Nymphaea alba, Saraca asoca, Hibiscus alba, Couroupita guianensis and Plumbago reosea. The bee-feed may alternatively or additionally include a herb extract obtained from atleast one of Plumeria rubra, Vinca rosea, Ageretum conzyoides, Calotropis gigantea, Calotropis procera, Nerium indicum, Thevetia neriifolia, Jasminum officinale, Jasminum auriculatum, Musa paradisiaca, Jasminum humile, Nyctanthes abor-tristis, Ocimum sanctum, Ocimum gratissimum, Tabernaemontana divaricata, Tridax procumbens, Cassia auriculata, Hibiscus vitifolius, Sesbania grandiflora, Nymphaea alba, Saraca asoca, Hibiscus alba, Couroupita guianensis and Plumbago reosea. In an embodiment, the herb extract may be obtained by techniques generally known in the art such as grinding, extraction, boiling, centrifugation, etc, of one or more medicinal plants. [0029] In an embodiment, the method includes maintaining a controlled system. The controlled system may be conditions that are generally considered suitable for honeybees to produce honey. In an embodiment, the controlled system includes maintaining a condition
wherein the temperature is in the range of 32°C and 36°C and relative humidity is in the range of 60% to75%. The beefeed may be provided for a preferable period of about 100 to 150 days. It would be apparent to a person skilled in the art that many modifications in the method may be practiced without departing from the scope of the present invention. [0030] The honey produced by the bees upon providing the bee-feed, according to the various embodiments herein, may be extracted by method generally known in the field. In an embodiment, extraction may be performed by removing honey super, looking for brood and managing appropriately, moving honey into hot houses and extracting honey using an extractor. The honey supers, after extraction may further be stored or returned to the hive. In an embodiment extraction of honey may be performed by generally known commercial extractors.
[0031] Fig. 1 depicts a flowchart for method of honey extraction. In another embodiment, extraction of honey may be performed by honey tapping using flow frame bee hives. Fig. 2 illustrates the method of flow frame technique of honey tapping. The flow frame beehives have partly formed honeycomb cells that are completed by the honeybees to store honey. Once the honeybees complete the comb cells with their wax and fill the cells with honey and cap it, honey can be extracted by opening the tap. Opening the tap will split the comb cells vertically allowing the honey to flow down which may then be collected without disturbing the honeybees. [0032] The honey produced according to the various embodiments herein may further be processed by method generally known in the field. In an embodiment, processing may be performed by techniques such as heating directly or indirectly, straining, filtration, etc. In a preferred embodiment, the raw honey is filtered and then heated under controlled conditions. Controlled conditions may be conditions suitable to purify and prevent honey from granulation. In one embodiment, controlled conditions for processing include controlled temperature of about 61°C to 63°C, for a maximum period of about 30 minutes and until the humidity is within the range of 18% to 22%. In an embodiment, heating is performed to ensure pasteurization and may be performed by using a power blanket or direct heat.
[0033] In an embodiment, the method of preparation of medicated honey may further include packaging of the processed honey in airtight amber color containers. It would be apparent to a person skilled in the art that many modifications in the method may be practiced
without departing from the scope of the present invention. Fig. 3 depicts a flowchart for method of processing medicated honey as disclosed in the various embodiments herein.
Treatment
[0034] Disclosed herein are embodiments of a method for the management and prevention of cancer. Also disclosed herein are methods of strengthening the immune system. In an embodiment, the method includes administering to a subject a suitable amount of medicated honey disclosed in the various embodiments herein.
[0035] Embodiments of the Disclosed composition may also find use in the preparation of a medicament having antioxidant properties. It may also be used in the preparation of medication for the prevention/management of cancer. Further embodiments of the disclosed composition may also be used as a medium for the administration of medicine. The term medicine may include any ayurvedic or allopathic medicine which may be mixed or triturated to improve its absorption or palatability. It may further include any therapeutic agent known to be administered with honey. [0036] In an embodiment, the honey administered may be raw honey or processed honey. In another embodiment, the honey may be combined with other ingredients such as minerals, vitamins, amino acids, herbal extracts, therapeutic agents, etc. The therapeutic agents that may be used include anti-oxidants, anticancer, antimicrobial, antiulcer, cytoprotective, chemoprotective, wound healing, anti-acne, hepatoprotective, antiviral, filaricidal, anti-allergy, anti-diabetic, analgesic, antipyretic agents and so on.
[0037] Subject may include any individual, child or adult. In an embodiment, subject includes an individual having cancer. In another embodiment, subject includes any individual having poor health conditions. In another embodiment, the disclosed honey may be used to improve general health of any individual. Accordingly, the subject may include any individual looking at improving general health.
[0038] Embodiments of the Disclosed formulation (also referred as Test substance) was further evaluated for cytotoxicity and anti-oxidant properties by studies, as described hereunder by way of examples. Embodiments are further described by reference to the following examples by way of illustration only and should not be construed to limit the scope of the claims provided herewith. It will be apparent to those skilled in the art that many modifications, both to materials and methods, may be practiced without departing from the scope of the claims.
Example 1; Evaluation of in vitro cytotoxicity of medicated honey on selected cell lines
[0039] Objective: The purpose of this Study is to evaluate the test substance(medicated honey) for its cytotoxicity against selected cell lines.
[0040] Summary: In-vitro cytotoxicity of the test substance (medicated honey) was tested by MTT on A549 (Human Lung Carcinoma), HeLa (Human Cervix Adenocarcinoma) and HL-60 (Human promyeloblast leukemia) cell lines. The test substance was taken at concentrations ranging from 1000 μg/ml to 7.&μ§/ηύ (i.e. 1000 μg/ml, 500μg/ml, 250μg/ml, 125μg/ml, 62^g/ml, 31.25μ /ηι1, 15^g/ml and 7^g/ml) to determine the percentage growth inhibition on the cell lines A549 and HeLa.
[0041] Observation: It was observed that the Test substance exhibited a CTC50 value of >1000 on all three cell lines (A549, HeLa and HL-60). Table 2 depicts the Cytotoxicity levels of test substance against A549 cell line. Table 3 depicts the Cytotoxicity levels of test substance against HeLa cell line. Table 4 depicts the Cytotoxicity levels of test substance against HL-60 cell line.
[0042] Table 2: Cytotoxic properties of test substances against A549 cell line
No Name of Test Substance Test Cone, ( g/ml) % Cytotoxicity CTC50 (ng/ml)
1. Medicated honey 1000 26.05+0.93
500 18.70+0.93
250 14.24+0.51
125 12.94+0.64 >1000
62.5 10.96+0.68
31.25 6.84+1.37
15.6 2.99+0.43
7.8 1.53+0.34
[0043] Table 3: Cytotoxic properties of test substances against HeLa cell line
No Name of Test Substance Test Cone, ( g/ml) % Cytotoxicity CTC50 ^g/ml)
1. Medicated honey 1000 24.97+1.02
500 18.70+0.93
250 14.24+0.51
125 12.94+0.64 >1000
62.5 10.96+0.68
[0044] Table 4: Cytotoxic properties of test substances against HL-60 cell line
Example 2: Evaluation of antioxidant activity of medicated honey. [0045] Objective: To assess the antioxidant activity of medicated honey by ABTS,
Nitric oxide, Hydroxyl radical and Reducing power assay method.
[0046] Summary: The antioxidant activity for ABTS at 2000 to
(i.e. 2(XX g/ml, l(XX g/ml, 500μ^πύ, 250μg/ml and 125μ^πύ), Nitric oxide at 5000 to 312.5μ§/ιη1
Hydroxyl radical and Ferric ion reducing power assay both at 1000 to 62.5μ§/ιη1 (1000μg/ml, 500μg/ml, 250μg/ml, 125μg/ml and 62^g/ml) were performed.
[0047] Observation: The antioxidant activity of the test samples exhibited the IC50 value of greater than 1000. The reducing power assay revealed the RPA value ranging from 0.082 to 0.024 for Medicated honey. Table 5 depicts the antioxidant activity of test substance for ABTS radical. Table 6 depicts the antioxidant activity of test substance for Nitric oxide radical. Table 7 depicts the antioxidant activity of test substance for Hydroxyl radical. Table 8 depicts the antioxidant activity of test substance for Hydroxyl radical.
[0048] Table 5: The antioxidant activity of test substance for ABTS radical
No Test Substance Concentration ^g/ml) % Inhibition IC50 g/ml)
1. Medicated 2000 61.83 + 0.95
honey 1000 36.47+ 3.66
500 33.28+2.65 1528.788
250 17.64+1.57 +1.05
125 12.01+1.79
[0049] Table 6: The antioxidant activity of test substance for Nitric oxide radical
No Test Substance Concentration ^g/ml) % Inhibition IC50 g/ml)
1. Medicated 5000 33.53 + 1.87
honey 2500 19.08+ 4.50
1250 16.01+3.54 >5000
625 -
312.5 9.53+3.56
[0050] Table 7: The antioxidant activity of test substance for Hydroxyl radical
[0051] Table 8: The antioxidant activity of test substance for Hydroxyl radical
[0052] The foregoing description of the specific embodiments will so fully reveal the general nature of the embodiments herein that others can, by applying current knowledge, readily modify and/or adapt for various applications such specific embodiments without departing from the generic concept, and, therefore, such adaptations and modifications should
and are intended to be comprehended within the meaning and range of equivalents of the disclosed embodiments. It is to be understood that the phraseology or terminology employed herein is for the purpose of description and not of limitation. Therefore, while the embodiments herein have been described in terms of preferred embodiments, those skilled in the art will recognize that the embodiments herein can be practiced with modification within the spirit and scope of the embodiments as described herein.
Claims
1. A medicated honey produced by a method comprising of: providing honeybees with a bee-feed obtained from at least one plant selected from a group consisting of Plumeria rubra, Vinca rosea, Ageretum conzyoides, Calotropis gigantea, Calotropis procera, Nerium indicum, Thevetia neriifolia, Jasminum officinale, Jasminum auriculatum, Musa paradisiaca, Jasminum humile, Nyctanthes abor-tristis, Ocimum sanctum, Ocimum gratissimum, Tabernaemontana divaricata, Tridax procumbens, Cassia auriculata, Hibiscus vitifolius, Sesbania grandiflora, Nymphaea alba, Saraca asoca, Hibiscus alba, Couroupita guianensis and Plumbago rose; extracting honey produced by the honeybees; and
processing the extracted honey.
2. The medicated honey as claimed in claim 1, wherein said bee-feed comprises of nectar obtained from at least one plant selected from a group consisting of Plumeria rubra, Vinca rosea, Ageretum conzyoides, Calotropis gigantea, Calotropis procera, Nerium indicum, Thevetia neriifolia, Jasminum officinale, Jasminum auriculatum, Musa paradisiaca, Jasminum humile, Nyctanthes abor-tristis, Ocimum sanctum, Ocimum gratissimum, Tabernaemontana divaricata, Tridax procumbens, Cassia auriculata, Hibiscus vitifolius, Sesbania grandiflora, Nymphaea alba, Saraca asoca, Hibiscus alba, Couroupita guianensis and Plumbago rosea.
3. The medicated honey as claimed in claim 1, wherein said bee-feed is provided in a controlled system.
4. The medicated honey as claimed in claim 3, wherein said controlled system comprises of condition including temperature of 32°C to 36°C and relative humidity of 60% to 75%.
5. The medicated honey as claimed in claim 1, wherein bee-feed is made available to the honeybees for a period of 100 to 150 days
6. The medicated honey as claimed in claim 1 , wherein said processing includes heating honey at a temperature ranging from 61°C to 63 °C and maintaining humidity in the range of 18% to 22%.
7. The medicated honey as claimed in claim 1, wherein said method further includes packaging in airtight amber color containers.
8. A method of producing medicated honey, comprising of: providing bees with a beefeed obtained from at least one plant selected from a group consisting of Plumeria rubra, Vinca rosea, Ageretum conzyoides, Calotropis gigantea, Calotropis procera, Nerium indicum, Thevetia neriifolia, Jasminum officinale, Jasminum auriculatum, Musa paradisiaca, Jasminum humile, Nyctanthes abor-tristis, Ocimum sanctum, Ocimum gratissimum, Tabernaemontana divaricata, Tridax procumbens, Cassia auriculata, Hibiscus vitifolius, Sesbania grandiflora, Nymphaea alba, Saraca asoca, Hibiscus alba, Couroupita guianensis and Plumbago rosea;
extracting honey produced by the honeybees; and
processing the extracted honey.
9. The method of producing medicated honey as claimed in claim 8, wherein said beefeed is provided in a controlled system.
10. The method of producing medicated honey as claimed in claim 8, wherein said controlled system comprises of condition including temperature in the range of 32°C to 36°C and a relative humidity of about75%.
11. The method of producing medicated honey as claimed in claim 8, wherein said bee-feed is made available to honeybees for a period of 100 to 150 days
12. The method of producing medicated honey as claimed in claim 8, wherein processing includes heating honey at a temperature in the range of 61°C to 63 °C and maintaining humidity in the range of 18% to 22%.
13. The method of producing medicated honey as claimed in claim 12, wherein heating may be performed or a period of 10 to 30 minutes.
14. Use of medicated honey claimed in claim 1, in strengthening the immune system.
15. Use of medicated honey claimed in claim 1, in the preparation of a medicament having antioxidant properties.
16. Use of medicated honey claimed in claim 1, as an anticancer agent.
17. Use of medicated honey claimed in claim 1, in the preparation of a medicament for the prevention/management of cancer.
18. Use of medicated honey claimed in claim 1, as a medium for the administration of medicine.
19. A method for prevention or management of cancer, comprising administering a therapeutically effective amount of medicated honey claimed in claim 1.
20. The method for the prevention or management of cancer as claimed in claim 19, wherein said medicated honey is administered along with administration of at least one other medication prescribed for the management of cancer.
21. A method for strengthening the immune system, comprising administering a therapeutically effective amount of medicated honey claimed in claim 1
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN201741029072 | 2017-08-16 | ||
IN201741029072 | 2017-08-16 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2019035143A2 true WO2019035143A2 (en) | 2019-02-21 |
WO2019035143A3 WO2019035143A3 (en) | 2019-06-13 |
Family
ID=65362737
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IN2018/050531 WO2019035143A2 (en) | 2017-08-16 | 2018-08-16 | Medicated honey and method of preparation thereof |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2019035143A2 (en) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL1016398C2 (en) * | 2000-10-13 | 2002-04-16 | Triticum Exploitatie B V | Composition based on a therapeutically active compound, in particular honey, for treating wounds. |
WO2006080019A1 (en) * | 2005-01-31 | 2006-08-03 | Tzuf Globus Ltd. | Bee-food, honey made by bees fed with it, and uses of such honey |
BRPI0814415A2 (en) * | 2007-07-26 | 2014-10-14 | Mieles Llovell S L | METHOD OF OBTAINING FOOD FOR BEES BASED ON VEGETABLE AND PRODUCT OBTAINED IN THIS WAY |
CN102813913A (en) * | 2012-09-12 | 2012-12-12 | 贵州神奇药业股份有限公司 | Sichuan blackberry extract composition |
FR3039228B1 (en) * | 2015-07-22 | 2020-01-03 | Safran Aircraft Engines | AIRCRAFT COMPRISING A CARENE REAR PROPELLER WITH INLET STATOR INCLUDING A BLOWING FUNCTION |
US11304983B2 (en) * | 2017-09-27 | 2022-04-19 | Muniyal Ayurvedic Research Centre | Medicated honey and method of preparation thereof |
-
2018
- 2018-08-16 WO PCT/IN2018/050531 patent/WO2019035143A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2019035143A3 (en) | 2019-06-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Njoku et al. | Phytochemical constituents of some selected medicinal plants | |
US11304983B2 (en) | Medicated honey and method of preparation thereof | |
CN109331095A (en) | A kind of clearing damp rash composition and preparation method thereof | |
Saba et al. | Honey: Food or medicine | |
Essiett et al. | Proximate composition and phytochemical constituents of Aspilia africana (Pers) CD Adams and Tithonia diversifolia (Hemsl) A. Gray stems (Asteraceae) | |
CN106860482A (en) | The application of propolis extracted with alcohol | |
US5561116A (en) | Solid product containing propolis components, and preparation and uses thereof | |
Kapare et al. | Nutritional and Therapeutic potential of Propolis: A Review | |
CN106047610A (en) | Yin nourishing and blood enrichment mulberry health preserving wine and preparation method thereof | |
KR101930264B1 (en) | Cosmetic composition for inhibiting secretion of sebum and for improving acne symptoms containing natural complex extract | |
KR100747415B1 (en) | Composition for improving mastitis comprising herb extracts | |
KR101661495B1 (en) | The method of Eco-friendly alcohol-free, water-soluble propolis using natural honey | |
KR100903827B1 (en) | The hand-made traditional oriental soap and the manufacture method | |
WO2019035143A2 (en) | Medicated honey and method of preparation thereof | |
EP3441076A1 (en) | Pharmaceutical product for treating tumor and combined immune defect, and preparation and application thereof | |
RU2544059C2 (en) | Selective honey and method of its production | |
Kumar et al. | Ethnobotanical and pharmacological review on Indigofera tinctoria | |
CN106591058A (en) | Propolis wine capable of enhancing immunity and preparation method thereof | |
Suara et al. | Neutraceutical and antibacterial properties of methanol extract of Plukenetia conophora [Müll.-Arg. family Euphorbiaceae] leaves and physical properties of its cream formulations | |
EP2793917B1 (en) | Extract of rhus copallina extract for use as a medicament | |
CN109224037A (en) | A kind of antibacterial cream of erysipelas and preparation method thereof | |
KR20200142768A (en) | Composition for hangover cure conprising oriental herbal extract | |
Jadhav et al. | Formulation and evaluation of ointment and liniment using Moringa oleifera seed extract | |
ATTAH | Antimicrobial effects of honey and its specific actions on cell walls, membranes and enzymes of some microbial pathogens | |
EA021203B1 (en) | Cinnamon- and basil-based composition for treating or preventing urinary infections and method for manufacture thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 18847015 Country of ref document: EP Kind code of ref document: A2 |